Page last updated: 2024-12-06

5-nitrouracil

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5-Nitrouracil is a synthetic compound that is an analog of uracil. It is a potent inhibitor of thymidylate synthase, an enzyme that is essential for the synthesis of thymine, a key component of DNA. This inhibition leads to the depletion of thymine nucleotides, which can disrupt DNA replication and ultimately cell proliferation. 5-Nitrouracil has been studied as a potential anticancer agent, particularly for the treatment of solid tumors. It has also been investigated for its potential to suppress the immune system, making it a potential therapeutic target for autoimmune diseases. The compound is typically synthesized via the nitration of uracil, a reaction that involves the introduction of a nitro group (-NO2) onto the uracil molecule. Research on 5-nitrouracil continues to explore its potential in various therapeutic applications and its impact on biological systems.'

5-nitrouracil: prevents thymidine degradation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

5-nitrouracil : A C-nitro compound consisting of uracil having a nitro group at the 5-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID69135
CHEMBL ID323780
CHEBI ID60763
SCHEMBL ID190925
SCHEMBL ID5780473
MeSH IDM0160755

Synonyms (62)

Synonym
nsc 9790
ai3-25473
einecs 210-250-4
5-nitropyrimidine-2,4-diol
AKOS002337367
AKOS002722690
2,4-dihydroxy-5-nitropyrimidine
5-nitro-1h-pyrimidine-2,4-dione
2,4(1h,3h)-pyrimidinedione, 5-nitro-
uracil, 5-nitro-
2,3h)-pyrimidinedione, 5-nitro-
nsc9790
nsc-9790
5-nitrouracil
611-08-5
5-nitrouracil, 98%
SR-01000390728-2
STK336423
5-nitropyrimidine-2,4(1h,3h)-dione
AKOS000399747
CHEBI:60763 ,
CHEMBL323780
N0281
STK633437
A8490
5-nitropyrimidine-2,4-diol;5-nitrouracil
5nu ,
CCG-50731
EPITOPE ID:138112
F0848-0340
4-hydroxy-5-nitropyrimidin-2(1h)-one
FT-0620726
STL336705
F0017-1804
BBL033938
AKOS022142015
AM83914
SCHEMBL190925
SCHEMBL5780473
DTXSID2060597
Q-200549
661-08-5
5-nitro-2,4(1h,3h)-pyrimidinedione #
AC-907/30002012
5-nitro-2,4(1h,3h)-pyrimidinedione
AKOS025293373
5-nitro-1,2,3,4-tetrahydropyrimidine-2,4-dione
STR04133
2,4(1h,3h)-pyrimidinedione-5-nitro
AC-23094
mfcd00006021
SR-01000390728-1
sr-01000390728
Z274568144
5-nitrouracil, 97%
SY001470
5-nitro-2.6-dioxypyrimidin
CS-W017981
Q27128575
furfurylthioacetate
EN300-73335
5-nitro-2,4-dihydroxypyrimidine
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
C-nitro compoundA nitro compound having the nitro group (-NO2) attached to a carbon atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
AID216186The compound was tested for antiviral activity against Herpes simplex virus type-1 in the vero cells using plaque inhibition assay; no IC50 reached without damage to the cell monolayer.1999Journal of medicinal chemistry, Aug-26, Volume: 42, Issue:17
Virtual combinatorial syntheses and computational screening of new potential anti-herpes compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (20.00)18.7374
1990's4 (26.67)18.2507
2000's1 (6.67)29.6817
2010's4 (26.67)24.3611
2020's3 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.10

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.10 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index5.30 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.10)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]